title: Effectiveness of second-line treatment in AL amyloidosis patient's refractory to M-Dex.
authors.affiliation: Service d'Hématologie, CHU, Limoges, France.
authors.forename: A
authors.initials: A
authors.lastname: Penot
authors.forename: J
authors.initials: J
authors.lastname: Abraham
authors.forename: H
authors.initials: H
authors.lastname: Debarri
authors.forename: E
authors.initials: E
authors.lastname: Desport
authors.forename: C
authors.initials: C
authors.lastname: Aguilar
authors.forename: D
authors.initials: D
authors.lastname: Lavergne
authors.forename: F
authors.initials: F
authors.lastname: Auroy
authors.forename: X
authors.initials: X
authors.lastname: Leleu
authors.forename: A
authors.initials: A
authors.lastname: Goldstein
authors.forename: B
authors.initials: B
authors.lastname: Kolb
authors.forename: F
authors.initials: F
authors.lastname: Bridoux
authors.forename: J P
authors.initials: JP
authors.lastname: Fermand
authors.forename: V
authors.initials: V
authors.lastname: Leblond
authors.forename: A
authors.initials: A
authors.lastname: Jaccard
mesh_terms: D000284:Administration, Oral; D000686:Amyloidosis / Q000188:drug therapy* / Q000276:immunology; D003907:Dexamethasone / Q000008:administration & dosage / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D007147:Immunoglobulin Light Chains; D008558:Melphalan / Q000008:administration & dosage / Q000627:therapeutic use*; D012008:Recurrence; D012189:Retrospective Studies
chemical_list: D007147:Immunoglobulin Light Chains; D003907:Dexamethasone; D008558:Melphalan